SoNAR-Global is a global consortium led by social scientists specializing in emerging infectious diseases (EID) and antimicrobial resistance (AMR). It will build a sustainable international social science network to engage the active participation of social sciences and promote complementarity and synergy in the governance of prevention and response to infectious threats and AMR. As such, it will become an integral part of emergency response. Partnering with major international and regional institutions, it will lead activities through a program that builds governance from the ground up. It will: • Develop an open-access platform to support the SoNAR-Global activities and to share them broadly. • Adapt, test, and evaluate vulnerability assessment tools on the ground and engagement models to facilitate collaboration across multiple stakeholders. • Create, pilot, and evaluate curricula for training social scientists in preparedness and response to infectious threats and through curricular development and piloting social science knowledge of infectious threats among non-social sciences actors.

The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest and most diverse research and service providing instrument to study infectious diseases in Europe, from structural biology to clinical trials. Giving scientists access to the whole extent of our state of the art facilities, cutting edge services, advanced equipment and expertise, in an integrated way and with a common goal, will enable or accelerate the generation of new knowledge and intervention tools to ultimately help control SARS CoV 2 in particular, and epidemic prone pathogens in general, while avoiding fragmentation and duplication among European initiatives. Such a global and interdisciplinary approach is meant to allow the implementation of user projects that are larger, more ambitious and more impactful than the EU supported transnational activities that the consortium is used to run. Our proposition is ambitious but achievable in a timely fashion due to the relevance and previous experience of the partners that we have gathered and that have complementary fields of expertise, which addresses the need for an interdisciplinary effort. Leveraging all these existing strengths to develop synergies will create an additional value and enhance Europe capacity for controlling emerging or re emerging and epidemic infectious diseases, starting with the COVID 19 pandemic. Such a global and coordinated approach is consistent with the recommendations of the One Health concept and necessary to make significant contributions to solving complex societal problems like epidemics and pandemics.